Reducing Gabaergic Inhibition Restores Cognitive Functions in a Mouse Model of Down Syndrome

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|13|1|8-15

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.1, 2014-02, pp. : 8-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lithium Restores Age-related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 7, 2017-10 ,pp. : 812-819

Bentham Science Publishers

Access to resources Recommend Favorite

Nicotine may improve cognitive performance in Down's syndrome

By  

Inpharma, Vol. 1, Iss. 1261, 2000-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Insights from Mouse Models to Understand Neurodegeneration in Down Syndrome

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 4, 2010-08 ,pp. : 429-438

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issues: Pharmacological Intervention for Down Syndrome Cognitive Deficits: Emerging Drug Targets)

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 1, 2014-02 ,pp. : 6-7

Bentham Science Publishers

Access to resources Recommend Favorite